Develops proprietary antibody drugs targeting cancer
ADC Therapeutics has raised €101M across 2 funding rounds, most recently a Growth/Late round in Sep 2015. Based in Epalinges, Switzerland; founded 2011; active in Healthtech. Data as of 6 Aug 2026.
Timing: dormant vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
| Date |
|---|
| Stage |
|---|
| Amount |
|---|
| Investors |
|---|
| 2015-09-01 | Growth/Late | €71M | — | View deal → |
| 2013-10-01 | Growth/Late | €30M | — | View deal → |
